EXTRAPYRAMIDAL FEATURES IN ADVANCED DOWNS-SYNDROME - CLINICAL-EVALUATION AND FAMILY HISTORY

被引:17
作者
VIEREGGE, P
ZIEMENS, G
FREUDENBERG, M
PIOSINSKI, A
MUYSERS, A
SCHULZE, B
机构
[1] LANDESKRANKENHAUS, HEILIGENHAFEN, GERMANY
[2] LANDESKRANKENHAUS, NEUSTADT, GERMANY
[3] PSYCHIAT KRANKENHAUS, RICKLING, GERMANY
[4] MED UNIV LUBECK, INST HUMANGENET, W-2400 LUBECK 1, GERMANY
关键词
D O I
10.1136/jnnp.54.1.34
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Extrapyramidal, frontal release, and other neurological signs were studied in 54 demented and non-demented patients with Down's syndrome (DS). Fourteen patients were demented and five showed extrapyramidal signs, mainly of the rigid-hypokinetic spectrum and similar to Parkinsonian features in advanced Alzheimer's disease (AD). None of the non-demented patients had Parkinsonian signs. The mean age of the demented DS patients with extrapyramidal signs was significantly higher than that of the patients without. Frontal release signs were present in demented and non-demented patients. A questionnaire showed no increase in either the proportion of early- or senile-onset dementia or Parkinsonism among first- and second-degree relatives of DS patients. Parkinsonian signs appear to be present at a lower frequency in DS than in advanced AD. A speculative hypothesis about a gene dosage effect of Cu/Zn-superoxide dismutase in preventing toxic radical formation in the substantia nigra of DS patients is presented.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 51 条
[1]   INHERITANCE OF ALZHEIMERS-DISEASE - EPIDEMIOLOGIC EVIDENCE [J].
CHANDRA, V ;
SCHOENBERG, BS .
NEUROEPIDEMIOLOGY, 1989, 8 (04) :165-174
[2]   CLINICAL SUBTYPES OF DEMENTIA OF THE ALZHEIMER TYPE [J].
CHUI, HC ;
TENG, EL ;
HENDERSON, VW ;
MOY, AC .
NEUROLOGY, 1985, 35 (11) :1544-1550
[3]  
Cohen G, 1983, J Neural Transm Suppl, V19, P89
[4]  
DALTON A J, 1974, Cortex, V10, P366
[5]  
DELWAIDE PJ, 1977, ACTA NEUROL SCAND, V56, P256
[6]   NEUROPATHOLOGIC AND CLINICAL-FEATURES OF PARKINSONS-DISEASE IN ALZHEIMERS-DISEASE PATIENTS [J].
DITTER, SM ;
MIRRA, SS .
NEUROLOGY, 1987, 37 (05) :754-760
[7]  
DRACHMAN DA, 1975, LANCET, V1, P809
[8]   TRANSGENIC MICE WITH INCREASED CU/ZN-SUPEROXIDE DISMUTASE ACTIVITY - ANIMAL-MODEL OF DOSAGE EFFECTS IN DOWN-SYNDROME [J].
EPSTEIN, CJ ;
AVRAHAM, KB ;
LOVETT, M ;
SMITH, S ;
ELROYSTEIN, O ;
ROTMAN, G ;
BRY, C ;
GRONER, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (22) :8044-8048
[9]  
Fahn S., 1987, RECENT DEV PARKINSON, V2, P153
[10]   THE SUBSTANTIA NIGRA AND VENTRAL TEGMENTAL AREA IN ALZHEIMERS-DISEASE AND DOWNS-SYNDROME [J].
GIBB, WRG ;
MOUNTJOY, CQ ;
MANN, DMA ;
LEES, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (02) :193-200